ARTIVION INC (AORT) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:AORT - US2289031005 - Common Stock
46.89 USD
-0.29 (-0.61%)
46.89 USD
0 (0%)
Taking everything into account, AORT scores 5 out of 10 in our fundamental rating. AORT was compared to 185 industry peers in the Health Care Equipment & Supplies industry. AORT has only an average score on both its financial health and profitability. AORT has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year AORT has reported negative net income.
In the past year AORT had a positive cash flow from operations.
In the past 5 years AORT always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: AORT reported negative operating cash flow in multiple years.
1.2 Ratios
With a decent Return On Assets value of -1.06%, AORT is doing good in the industry, outperforming 71.35% of the companies in the same industry.
The Return On Equity of AORT (-2.08%) is better than 71.35% of its industry peers.
AORT has a better Return On Invested Capital (2.28%) than 68.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.06% | ||
| ROE | -2.08% | ||
| ROIC | 2.28% |
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
AORT has a better Operating Margin (5.26%) than 69.73% of its industry peers.
In the last couple of years the Operating Margin of AORT has grown nicely.
AORT has a better Gross Margin (64.50%) than 65.95% of its industry peers.
In the last couple of years the Gross Margin of AORT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.26% | ||
| PM (TTM) | N/A | ||
| GM | 64.5% |
OM growth 3Y34.21%
OM growth 5Y6.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AORT is destroying value.
Compared to 1 year ago, AORT has more shares outstanding
Compared to 5 years ago, AORT has more shares outstanding
AORT has a worse debt/assets ratio than last year.
2.2 Solvency
AORT has an Altman-Z score of 4.02. This indicates that AORT is financially healthy and has little risk of bankruptcy at the moment.
AORT has a Altman-Z score of 4.02. This is in the better half of the industry: AORT outperforms 74.05% of its industry peers.
AORT has a debt to FCF ratio of 12.48. This is a negative value and a sign of low solvency as AORT would need 12.48 years to pay back of all of its debts.
AORT has a Debt to FCF ratio of 12.48. This is in the better half of the industry: AORT outperforms 71.89% of its industry peers.
AORT has a Debt/Equity ratio of 0.50. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of AORT (0.50) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 12.48 | ||
| Altman-Z | 4.02 |
ROIC/WACC0.27
WACC8.46%
2.3 Liquidity
AORT has a Current Ratio of 3.93. This indicates that AORT is financially healthy and has no problem in meeting its short term obligations.
AORT has a better Current ratio (3.93) than 67.57% of its industry peers.
AORT has a Quick Ratio of 2.88. This indicates that AORT is financially healthy and has no problem in meeting its short term obligations.
AORT's Quick ratio of 2.88 is fine compared to the rest of the industry. AORT outperforms 63.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.93 | ||
| Quick Ratio | 2.88 |
3. Growth
3.1 Past
The earnings per share for AORT have decreased strongly by -85.71% in the last year.
The Revenue has grown by 9.81% in the past year. This is quite good.
AORT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.06% yearly.
EPS 1Y (TTM)-85.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%220%
Revenue 1Y (TTM)9.81%
Revenue growth 3Y9.14%
Revenue growth 5Y7.06%
Sales Q2Q%16.3%
3.2 Future
The Earnings Per Share is expected to grow by 46.17% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 11.94% on average over the next years. This is quite good.
EPS Next Y148.8%
EPS Next 2Y75.22%
EPS Next 3Y53.35%
EPS Next 5Y46.17%
Revenue Next Year12.7%
Revenue Next 2Y11.83%
Revenue Next 3Y11.75%
Revenue Next 5Y11.94%
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
AORT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 101.90 indicates a quite expensive valuation of AORT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AORT indicates a somewhat cheap valuation: AORT is cheaper than 65.95% of the companies listed in the same industry.
AORT is valuated expensively when we compare the Price/Forward Earnings ratio to 24.03, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 101.9 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AORT indicates a somewhat cheap valuation: AORT is cheaper than 65.95% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, AORT is valued a bit cheaper than 68.65% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 126.92 | ||
| EV/EBITDA | 52.32 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AORT's earnings are expected to grow with 53.35% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y75.22%
EPS Next 3Y53.35%
5. Dividend
5.1 Amount
AORT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
46.89
-0.29 (-0.61%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners87.11%
Inst Owner ChangeN/A
Ins Owners4.19%
Ins Owner Change-5.25%
Market Cap2.22B
Revenue(TTM)422.65M
Net Income(TTM)-9.12M
Analysts83.08
Price Target52.75 (12.5%)
Short Float %2.76%
Short Ratio3.29
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1085.72%
Min EPS beat(2)243.19%
Max EPS beat(2)1928.24%
EPS beat(4)3
Avg EPS beat(4)431.47%
Min EPS beat(4)-537.25%
Max EPS beat(4)1928.24%
EPS beat(8)6
Avg EPS beat(8)226.74%
EPS beat(12)8
Avg EPS beat(12)127.86%
EPS beat(16)11
Avg EPS beat(16)63.37%
Revenue beat(2)1
Avg Revenue beat(2)0.73%
Min Revenue beat(2)-1.12%
Max Revenue beat(2)2.59%
Revenue beat(4)2
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-5.37%
Max Revenue beat(4)2.59%
Revenue beat(8)4
Avg Revenue beat(8)0.31%
Revenue beat(12)7
Avg Revenue beat(12)0.63%
Revenue beat(16)10
Avg Revenue beat(16)0.6%
PT rev (1m)14.27%
PT rev (3m)21.97%
EPS NQ rev (1m)-13.05%
EPS NQ rev (3m)19.99%
EPS NY rev (1m)86.52%
EPS NY rev (3m)81.82%
Revenue NQ rev (1m)0.26%
Revenue NQ rev (3m)0.72%
Revenue NY rev (1m)0.92%
Revenue NY rev (3m)0.86%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 101.9 | ||
| P/S | 5.26 | ||
| P/FCF | 126.92 | ||
| P/OCF | 72.92 | ||
| P/B | 5.06 | ||
| P/tB | 79.73 | ||
| EV/EBITDA | 52.32 |
EPS(TTM)-0.26
EYN/A
EPS(NY)0.46
Fwd EY0.98%
FCF(TTM)0.37
FCFY0.79%
OCF(TTM)0.64
OCFY1.37%
SpS8.92
BVpS9.26
TBVpS0.59
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.06% | ||
| ROE | -2.08% | ||
| ROCE | 2.88% | ||
| ROIC | 2.28% | ||
| ROICexc | 2.52% | ||
| ROICexgc | 6.11% | ||
| OM | 5.26% | ||
| PM (TTM) | N/A | ||
| GM | 64.5% | ||
| FCFM | 4.14% |
ROA(3y)-2.68%
ROA(5y)-2.4%
ROE(3y)-7.46%
ROE(5y)-6.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y40.9%
ROICexgc growth 5Y5.66%
ROICexc growth 3Y48.24%
ROICexc growth 5Y9.09%
OM growth 3Y34.21%
OM growth 5Y6.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.05%
GM growth 5Y-0.68%
F-Score5
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 12.48 | ||
| Debt/EBITDA | 4.81 | ||
| Cap/Depr | 56.35% | ||
| Cap/Sales | 3.07% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 67.34% | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.93 | ||
| Quick Ratio | 2.88 | ||
| Altman-Z | 4.02 |
F-Score5
WACC8.46%
ROIC/WACC0.27
Cap/Depr(3y)42.06%
Cap/Depr(5y)43.23%
Cap/Sales(3y)2.8%
Cap/Sales(5y)3.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-85.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%220%
EPS Next Y148.8%
EPS Next 2Y75.22%
EPS Next 3Y53.35%
EPS Next 5Y46.17%
Revenue 1Y (TTM)9.81%
Revenue growth 3Y9.14%
Revenue growth 5Y7.06%
Sales Q2Q%16.3%
Revenue Next Year12.7%
Revenue Next 2Y11.83%
Revenue Next 3Y11.75%
Revenue Next 5Y11.94%
EBIT growth 1Y-25.58%
EBIT growth 3Y46.49%
EBIT growth 5Y14.43%
EBIT Next Year115.81%
EBIT Next 3Y44.55%
EBIT Next 5Y34.17%
FCF growth 1Y4464.09%
FCF growth 3YN/A
FCF growth 5Y7.33%
OCF growth 1Y292.01%
OCF growth 3YN/A
OCF growth 5Y7.04%
ARTIVION INC / AORT FAQ
Can you provide the ChartMill fundamental rating for ARTIVION INC?
ChartMill assigns a fundamental rating of 5 / 10 to AORT.
Can you provide the valuation status for ARTIVION INC?
ChartMill assigns a valuation rating of 4 / 10 to ARTIVION INC (AORT). This can be considered as Fairly Valued.
Can you provide the profitability details for ARTIVION INC?
ARTIVION INC (AORT) has a profitability rating of 4 / 10.
Can you provide the financial health for AORT stock?
The financial health rating of ARTIVION INC (AORT) is 6 / 10.